NCT06457178

Brief Summary

The goal of this clinical trial is to investigate the effectiveness of Acceptance and Commitment Therapy Based Intervention for Oncology Patients. The main questions it aims to answer are:

  • Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of psychological distress?
  • Does the Acceptance and Commitment to Therapy-Based Intervention for Oncology Patients affect the level of reintegration into normal life? Researchers will compare Acceptance and Commitment Therapy-Based Intervention for Oncology Patients (ACT) to Psychoeducation for Oncology Patients and routine care (with no specific intervention) to see if Acceptance and Commitment Therapy-Based Intervention for Oncology Patients is effective in psychological distress and reintegration into normal living.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2024

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
12 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

June 3, 2025

Status Verified

June 1, 2025

Enrollment Period

7 months

First QC Date

May 17, 2024

Last Update Submit

June 1, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • The Distress Thermometer (DT)

    The scale was developed to measure psychological distress in cancer patients. The problems in the list are grouped into five areas. These are daily life problems, family problems, emotional problems, faith-related problems, and physical problems. The patient marks which one or which areas of the list he/she has experienced problems in the last week. The cut-off point of the scale in our country was found to be 4. The National Comprehensive Cancer Network (NCCN) argues that patients who score 5 or above on the distress thermometer are in significant distress and should be supported by professionals.

    1 day before intervention start

  • The Distress Thermometer (DT)

    The scale was developed to measure psychological distress in cancer patients. The problems in the list are grouped into five areas. These are daily life problems, family problems, emotional problems, faith-related problems, and physical problems. The patient marks which one or which areas of the list he/she has experienced problems in the last week. The cut-off point of the scale in our country was found to be 4. The National Comprehensive Cancer Network (NCCN) argues that patients who score 5 or above on the distress thermometer are in significant distress and should be supported by professionals.

    through study completion, an average of 1 year

  • The Distress Thermometer (DT)

    The scale was developed to measure psychological distress in cancer patients. The problems in the list are grouped into five areas. These are daily life problems, family problems, emotional problems, faith-related problems, and physical problems. The patient marks which one or which areas of the list he/she has experienced problems in the last week. The cut-off point of the scale in our country was found to be 4. The National Comprehensive Cancer Network (NCCN) argues that patients who score 5 or above on the distress thermometer are in significant distress and should be supported by professionals.

    one month after the end of the interventions

Secondary Outcomes (3)

  • Reintegration to Normal Living Index (RNLI)

    1 day before intervention start

  • Reintegration to Normal Living Index (RNLI)

    through study completion, an average of 1 year

  • Reintegration to Normal Living Index (RNLI)

    one month after the end of the interventions

Study Arms (3)

Acceptance and Commitment Therapy Based Intervention for Oncology Patients

EXPERIMENTAL

Group 1 will participate in a 5-session Acceptance and Commitment Therapy-Based Intervention for Oncology Patients intervention program.

Behavioral: Acceptance and Commitment Therapy-Based Intervention for Oncology Patients

Psychoeducation for Oncology Patients

ACTIVE COMPARATOR

Group 2 will participate in a 5-session Psychoeducation for Oncology Patients program.

Behavioral: Psychoeducation for Oncology Patients

Routine Care

NO INTERVENTION

During this period, participants in group 3 will continue their routine treatment.

Interventions

An intervention program was prepared for oncology patients aiming to reduce psychological distress and increase participation in normal life.

Acceptance and Commitment Therapy Based Intervention for Oncology Patients

A program was prepared to support oncology patients in physical and psychological symptom management.

Psychoeducation for Oncology Patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older,
  • Being able to read and write,
  • Receiving oncologic treatment,
  • Being diagnosed with breast cancer,
  • To know about Medical Diagnosis,
  • Being in stage 1, 2 or 3 of the disease,
  • Receiving outpatient chemotherapy treatment only,
  • Internet access and computer skills to participate in online group interviews,
  • Low to moderate scores on the brief psychological resilience scale,

You may not qualify if:

  • Having serious psychiatric or cognitive impairments that limit adherence to group sessions,
  • Having a physical disability that may make it difficult to participate in group sessions,
  • Failure to attend sessions regularly and absenteeism,
  • Currently being in a psychoeducation/psychotherapy group

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Acibadem Hospital

Istanbul, Turkey (Türkiye)

RECRUITING

Study Officials

  • Dilara Sert Kasım, M.Sc.

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR
  • Hülya Bilgin, Ph.D.

    Istanbul University - Cerrahpasa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dilara Sert Kasım, M.Sc.

CONTACT

Hülya Bilgin, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctorate Student

Study Record Dates

First Submitted

May 17, 2024

First Posted

June 13, 2024

Study Start

June 1, 2025

Primary Completion

December 30, 2025

Study Completion

January 30, 2026

Last Updated

June 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations